# A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282

> **NCT06858865** · PHASE1 · COMPLETED · sponsor: **Addpharma Inc.** · enrollment: 60 (actual)

## Conditions studied

- Primary Hypercholesterolaemia

## Interventions

- **DRUG:** AD-228A
- **DRUG:** AD-2281 and AD-2282

## Key facts

- **NCT ID:** NCT06858865
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-12
- **Primary completion:** 2025-08-14
- **Final completion:** 2025-08-14
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06858865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06858865, "A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06858865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*